The anchor trials are STEP (semaglutide for weight management, The New England Journal of Medicine , 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024)
(21) Literature Reviews Four literature reviews were included: three compared GLP-1 receptor agonists to other hypoglycemic agents, and one focused specifically on their effects on bone health
Re-engineering junk food to get more people addicted and chronically ill should absolutely be illegal and have strict government oversight with hard consequences for those co.'s that do not adhere
While commonly noted sebaceous hyperplasia has not been associated with MTS, any sebaceous lesion with atypical or difficult-to-classify histological features warrants prompt exploration of the patient's personal history and family history
Su efecto positivo en el aumento de la masa muscular en los participantes indica una mejora significativa en la funcin fsica de las personas con distrofia muscular
